Xiaoli Meng

20PUBLICATIONS
35CO-AUTHORS
Medical infection agents (incl. prions)Characterisation of biological macromoleculesMolecular medicineMolecular targetsBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Aug 17, 2026
In-Vitro Generation of T-Cell Clones to Difluorophenylglyoxal: Implications for Understanding the Immunogenicity of MK-3207.

|Feb 12, 2026
Insights into the Biochemical and Immune Mechanisms in Drug-Induced Liver Injury Pathogenesis.

Eleanor Saville, Georgia Wells, Liam Farrell

|Jun 21, 2025
TSC22 domain family member 3 links natural killer cells to CD8+ T cell-mediated drug hypersensitivity.

Lele Sun, Pengcheng Huai, Zhenzhen Wang

|May 06, 2025
Bioactivation of the β-Amyloid Precursor Protein-Cleaving Enzyme 1 Inhibitor Atabecestat Leads to Protein Adduct Formation on Glutathione S-Transferase Pi.

Megan Ford, Paul J Thomson, Adam Lister

|Dec 11, 2024
CYP3A4-Mediated Bioactivation of the β-Amyloid Precursor Protein-Cleaving Enzyme 1 Inhibitor JNJ-54861911 Results in Redox-Neutral Addition of Glutathione via Catalysis by Glutathione S-Transferase α1, Identified as the Major Target Protein in Human Hepatocytes.

Laurent Leclercq, Ronald de Vries, Valérie Koppen

|Sep 30, 2024
Selective HLA Class II Allele-Restricted Activation of Atabecestat Metabolite-Specific Human T-Cells.

Megan Ford, Paul J Thomson, Jan Snoeys

Pageof 4

Frequent Collaborators

8 joint publications

Dean Naisbitt

2 joint publications

Filip Cuyckens

2 joint publications

Laurent Leclercq

2 joint publications

Adam Lister